NR
Nicola Re
Sr Director Chemical Operations Italy at Olon
View Nicola's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Oct 2020 - Present · 4 years and 2 months
Sr Director Chemical Operations Italy
Jun 2024 - Present · 6 months
Chemical Operations Director Italy
Mar 2022 - Sep 2024 · 2 years and 6 months
Operations Director
Oct 2020 - Mar 2022 · 1 years and 5 months
Company Details
1001-5000 Employees
Olon is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and Generics. We supply more than 300 Active Pharmaceutical Ingredients globally, with one of the most extensive track records in the industry. We provide an integrated package of chemical synthesis and biological processing services which clients can use to manage their drug manufacturing projects fully compliant with regulations. We rely on the broadest technical expertise while maintaining a long-standing quality and reliability Thanks to 2.300 employees and 300 highly experienced and qualified people in R&D team, we are a highly reliable partner. Our global manufacturing networks implies 11 manufacturing sites and 7 R&D departments across the globe, on several decades of experience in supporting pharmaceutical, biotech, food, chemical and bio-industrial companies.
Year Founded
1987
Social Media
Linkedin
Industry
Chemical Manufacturing, Antibiotics NES, Chemical base materials, Chemicals, Pharmaceuticals & Plastics, Acetylsalicylic acid for pharmaceuticals, Cortisone and hydrocortisone preparations, Penicillin, derivatives and preparations, Raw materials for pharmaceuticals, Barbiturates, sulphonamides, glycosides, alkaloids and antibiotics, Hormones
HQ Location
Strada Rivoltana, km 6/7 - Rodano (MI) Italy Milan, Lombardia 20053, IT
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Nicola Re in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.